RTW Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.1M | Hold |
1,707,402
| – | – | 0.88% | 30 |
|
|
2025
Q1 | $61.8M | Sell |
1,707,402
-260,600
| -13% | -$9.44M | 0.95% | 27 |
|
|
2024
Q4 | $82.8M | Hold |
1,968,002
| – | – | 1.25% | 27 |
|
|
2024
Q3 | $109M | Sell |
1,968,002
-1,291,925
| -40% | -$71.8M | 1.58% | 27 |
|
|
2024
Q2 | $134M | Sell |
3,259,927
-3,827,188
| -54% | -$157M | 2.07% | 18 |
|
|
2024
Q1 | $331M | Buy |
7,087,115
+200,029
| +3% | +$9.34M | 4.88% | 4 |
|
|
2023
Q4 | $329M | Buy |
6,887,086
+1,481,997
| +27% | +$70.9M | 5.14% | 6 |
|
|
2023
Q3 | $193M | Hold |
5,405,089
| – | – | 4.07% | 9 |
|
|
2023
Q2 | $249M | Buy |
5,405,089
+1,134,093
| +27% | +$52.3M | 4.75% | 6 |
|
|
2023
Q1 | $171M | Buy |
4,270,996
+304,081
| +8% | +$12.2M | 3.57% | 10 |
|
|
2022
Q4 | $184M | Buy |
3,966,915
+1,606,919
| +68% | +$74.4M | 3.75% | 9 |
|
|
2022
Q3 | $97.7M | Buy |
2,359,996
+986,712
| +72% | +$40.9M | 2.25% | 15 |
|
|
2022
Q2 | $81.9M | Hold |
1,373,284
| – | – | 2.12% | 16 |
|
|
2022
Q1 | $99.7M | Hold |
1,373,284
| – | – | 2.06% | 20 |
|
|
2021
Q4 | $115M | Buy |
+1,373,284
| New | +$115M | 1.69% | 18 |
|